FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

921018011000036102: Exforge HCT 10/160/25 (amlodipine 10 mg + hydrochlorothiazide 25 mg + valsartan 160 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3766561000168110 Exforge HCT 10/160/25 tablet en Synonym Active Case sensitive Australian Medicines Terminology module
3766571000168116 Exforge HCT 10/160/25 (amlodipine 10 mg + hydrochlorothiazide 25 mg + valsartan 160 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Exforge HCT 10/160/25 tablet has manufactured dose form tablet true Inferred relationship Some
Exforge HCT 10/160/25 tablet has Australian BoSS amlodipine true Inferred relationship Some 1094163052
Exforge HCT 10/160/25 tablet Is a trade product unit of use true Inferred relationship Some
Exforge HCT 10/160/25 tablet Is a Exforge HCT 10/160/25 true Inferred relationship Some
Exforge HCT 10/160/25 tablet Is a amlodipine 10 mg + valsartan 160 mg + hydrochlorothiazide 25 mg tablet true Inferred relationship Some
Exforge HCT 10/160/25 tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Exforge HCT 10/160/25 tablet has intended active ingredient hydrochlorothiazide true Inferred relationship Some 166785630
Exforge HCT 10/160/25 tablet has unit of use tablet true Inferred relationship Some 1447536471
Exforge HCT 10/160/25 tablet has Australian BoSS hydrochlorothiazide true Inferred relationship Some 166785630
Exforge HCT 10/160/25 tablet has intended active ingredient amlodipine true Inferred relationship Some 1094163052
Exforge HCT 10/160/25 tablet has Australian BoSS valsartan true Inferred relationship Some 1447536470
Exforge HCT 10/160/25 tablet has intended active ingredient valsartan true Inferred relationship Some 1447536470

Inbound Relationships Type Active Source Characteristic Refinability Group
Exforge HCT 10/160/25 tablet, 28, blister pack has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 30 has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 56 has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 7 has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 14 has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 28 has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 7, blister pack has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 30, blister pack has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 14, blister pack has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1
Exforge HCT 10/160/25 tablet, 56, blister pack has TPUU True Exforge HCT 10/160/25 tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start